Treatment of growth hormone deficiency in adults.
BACKGROUND
The Growth Hormone Research Society held a Consensus Workshop in Sydney, Australia, in March 2007 to review advances in the management of growth hormone (GH) deficiency in adults and to update consensus recommendations.


OBJECTIVE
This short review summarizes key background information presented at the workshop and the consensus recommendations that followed.


CONCLUSIONS
The benefits of GH replacement in GH-deficient adults are evident throughout life. Clinical response to treatment should be assessed by monitoring biochemistry values, body composition and quality of life. There is no evidence that GH replacement increases the risk of tumour recurrence or de novo malignancy.
Johannsson
Gudmundur
G
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden. gudmundur.johannsson@medic.gu.se
D000328:Adult; D003920:Diabetes Mellitus / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D006130:Growth Disorders / Q000628:therapy*; D006287:Health Planning Guidelines; D019382:Human Growth Hormone / Q000009:adverse effects / Q000172:deficiency*; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced; D055815:Young Adult
D019382:Human Growth Hormone